In Reply
- PMID: 28851761
- PMCID: PMC5728029
- DOI: 10.1634/theoncologist.2017-0320
In Reply
Abstract
This Letter to the Editor responds to concerns regarding a recently published analysis of BRCA1 and BRCA2 variant classifications between a single testing laboratory (Myriad Genetic Laboratories) and a database of user‐submitted variant classifications (ClinVar).
Comment on
-
Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.Oncologist. 2017 Jul;22(7):797-803. doi: 10.1634/theoncologist.2016-0431. Epub 2017 Apr 13. Oncologist. 2017. PMID: 28408614 Free PMC article.
-
ClinVar Is a Critical Resource to Advance Variant Interpretation.Oncologist. 2017 Dec;22(12):1562. doi: 10.1634/theoncologist.2017-0246. Epub 2017 Aug 29. Oncologist. 2017. PMID: 28851762 Free PMC article.
References
-
- Daly M, Pilarski R, Berry M et al. Genetic/Familial High‐Risk Assessment: Breast and Ovarian. NCCN Clinical Practice Guidelines in Oncology; 2016.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous